MACLEODS PHARMA UK LIMITED — Febuxostat Importer Profile
Pharmaceutical Importer · #11 buyer for Febuxostat · $261.6K import value · 16 shipments · UNITED KINGDOM · DGFT Verified
MACLEODS PHARMA UK LIMITED is the #11 importer of Febuxostat from India with $261.6K in import value and 16 verified shipments. MACLEODS PHARMA UK LIMITED holds a 1.2% market share in Febuxostat imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 10 formulations shipped to 1 country.
MACLEODS PHARMA UK LIMITED — Febuxostat Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Febuxostat to MACLEODS PHARMA UK LIMITED?
Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $261.6K | 16 | 100.0% |
MACLEODS PHARMA UK LIMITED sources Febuxostat from 1 verified Indian supplier based on 16 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does MACLEODS PHARMA UK LIMITED Compare to Nearest Febuxostat Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | MARCAN PHARMACEUTICALS INC | CANADA | $600.0K | 12 | $50.0K |
| 8 | TEVA PHARMACEUTICALS WORKS PVT LTD | HUNGARY | $600.0K | 12 | $50.0K |
| 11 | MACLEODS PHARMA UK LIMITED ★ | UNITED KINGDOM | $581.0K | 16 | $36.3K |
| 13 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $542.2K | 22 | $24.6K |
| 14 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $537.0K | 11 | $48.8K |
MACLEODS PHARMA UK LIMITED ranks #11 among 421 Febuxostat importers from India. Average shipment value of $36.3K compared to the market average of $26.8K. The closest competitors by value are MARCAN PHARMACEUTICALS INC and TEVA PHARMACEUTICALS WORKS PVT LTD.
Where Does MACLEODS PHARMA UK LIMITED Import Febuxostat To?
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $261.6K | 16 | 100.0% |
MACLEODS PHARMA UK LIMITED imports Febuxostat to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $261.6K.
What Febuxostat Formulations Does MACLEODS PHARMA UK LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| FEBUXOSTAT 120MG TABLETS BNO:BFN2301A MFG. DT. SEP-2023 EXP. DT. AUG-2026 PS: 2X14S | $50.0K | 1 |
| FEBUXOSTAT 120MG TABLETS BNO:14242915A MFG DT:11/2024 EXP DT:10/2027 PS: 2X14S | $50.0K | 1 |
| FEBUXOSTAT 80MG TABLETS BNO:BFM2303A MFG | $29.3K | 1 |
| FEBUXOSTAT 80MG TABLETS, BNO. BFM2203A, | $27.7K | 1 |
| FEBUXOSTAT 80MG TABLETS BATCH NO 14250778A MFG DT 02 2025 EXP DT 01 2028 | $24.7K | 1 |
| FEBUXOSTAT 80MG TABLETS BNO:BFM2305A MFG. DT. DEC-2023 EXP. DT. NOV-2026 PS: 2X14SNOS | $24.6K | 3 |
| FEBUXOSTAT 80MG TABLETS BNO:14240554B MFG DT:05/2024 EXP DT:04/2027 PS: 2X14S | $24.6K | 1 |
| FEBUXOSTAT 120MG TABLETS BNO:BFN2401A MFG DT:02/2024 EXP DT:02/2027 PS: 2X14S | $13.2K | 3 |
| FEBUXOSTAT 120MG TABLETS PACK SIZE-2 X14 DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES | $13.0K | 3 |
| FEBUXOSTAT 120MG TABLETS, BNO. BFN2206A, | $4.4K | 1 |
MACLEODS PHARMA UK LIMITED imports 10 distinct Febuxostat formulations from India. The top formulation is FEBUXOSTAT 120MG TABLETS BNO:BFN2301A MFG. DT. SEP-2023 EXP. with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Febuxostat into United Kingdom
What MACLEODS PHARMA UK LIMITED and other importers must comply with to import Febuxostat from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Febuxostat
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Febuxostat from India and How Much Does MACLEODS PHARMA UK LIMITED Import?
India exported $11.3M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. MACLEODS PHARMA UK LIMITED imports $261.6K of this total, accounting for 1.2% of India's Febuxostat exports with 16 shipments from UNITED KINGDOM. This is verified from 16 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for MACLEODS PHARMA UK LIMITED's Febuxostat Imports?
MACLEODS PHARMA UK LIMITED's average Febuxostat order value is $16.3K per consignment, based on 16 shipments totaling $261.6K. MACLEODS PHARMA UK LIMITED is based in UNITED KINGDOM and ranks #11 among all Febuxostat importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Febuxostat to MACLEODS PHARMA UK LIMITED?
MACLEODS PHARMA UK LIMITED sources Febuxostat from 1 verified Indian supplier: MACLEODS PHARMACEUTICALS LIMITED ($261.6K, 100.0%). This is based on 16 customs records.
How Does MACLEODS PHARMA UK LIMITED Compare to Other Febuxostat Importers?
MACLEODS PHARMA UK LIMITED ranks #11 among 421 Febuxostat importers from India with a 1.2% market share. The top 3 importers are UNILAB INC ($1.9M), AJANTA PHARMA PHILIPPINES INC ($1.3M), J. KNIPPER & COMPANY, ($1.1M). MACLEODS PHARMA UK LIMITED processed 16 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MACLEODS PHARMA UK LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MACLEODS PHARMA UK LIMITED's capped import value divided by total capped export value for Febuxostat across all Indian exporters.
- 5.Verified Records: This page is backed by 16 individual customs records matching MACLEODS PHARMA UK LIMITED importing Febuxostat, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Import Data for MACLEODS PHARMA UK LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MACLEODS PHARMA UK LIMITED's Febuxostat imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MACLEODS PHARMA UK LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
MACLEODS PHARMA UK LIMITED × Febuxostat
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MACLEODS PHARMA UK LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current order-level data, contact TransData Nexus.